StockGlow

Biogen Inc. (BIIB)

$200.62+0.01%
Market signal
81
Bullish
BearishBullish

The outlook

Biogen is trading near the upper end of its 52-week range, comfortably above its moving averages, with analyst consensus leaning toward a Buy rating. The average analyst price target sits roughly 13% above the current price of $200.62. The overall market signal is firmly bullish based on current data.

What's behind the signal

Analyst consensusBuy — 1.9 avg of 30 analysts
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Price targetAvg target +13% vs current price
Market cap
$29.62B
52-wk high
$219.72
52-wk low
$124.56
50-day avg
$199.37
200-day avg
$181.70
Trailing P/E
21.3

The “market signal” is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works